Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-01-28 @ 1:54 PM
Study NCT ID:
NCT02689869
Status:
UNKNOWN
Last Update Posted:
2021-05-07
First Post:
2016-02-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma
Sponsor:
Ludwig-Maximilians - University of Munich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2014-005164-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None